QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Completes 1st Commercial Scale Fermentation Run of CBG
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) today announced its completion of the first commercial scale fermentation run of its first cannabinoid for market, cannabigerol ("CBG"). "We are very pleased with the yield and quality of our first commercial scale fermentation run of CBG," said Trevor Peters, Willow's president and chief executive officer. "I think it is important to take a moment to reflect on all that we have achieved in just under two years as a public company. In this time, we built a world class industrial R&D team, demonstrated proof of concept for production of cannabinoids through fermentation, attracted…